Catatonia: A review

Annals of Clinical Psychiatry

Volumn 20, Issue 2, 2008, Pages 97-107

  Weder, Natalie D ^a   Muralee, Sunanda ^a   Penland, Heath ^a   Tampi, Rajesh R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale New Haven Psychiatric Hospital   (United States)

Author keywords

Catatonia; Catatonic schizophrenia; Malignant catatonia; Neuroleptic malignant syndrome; Stupor

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; IOMAZENIL; LORAZEPAM; MEMANTINE; OXAZEPAM; PLACEBO; TOPIRAMATE; VALPROATE SEMISODIUM; ZOLPIDEM;

AGITATION; CATALEPSY; CATATONIA; CATATONIC SCHIZOPHRENIA; CLINICAL FEATURE; CLINICAL TRIAL; COCHRANE LIBRARY; COMORBIDITY; DATA BASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG BINDING; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EMBASE; HUMAN; MEDLINE; MONOTHERAPY; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; PSYCINFO; REVIEW; RISK FACTOR; STUPOR; TREATMENT RESPONSE;

CATATONIA; HUMANS;

EID: 45949105328     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: 10.1080/10401230802017092     Document Type: Review

References (101)

1. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160:1233-1241.
2. Pfuhlmann B, Stober G. The different conceptions of catatonia: historical overview and critical discussion. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl1):I4-I7.
3. Stober G, Pfuhlmann B, Nurnberg G, Schmidtke A, Reis A, Franzek E, Wienker TF. Towards the genetic basis of periodic catatonia: pedigree sample for genome scan I and II. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 1):I25-I30.
4. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160:4-12.
5. Fujii DE, Ahmed I. Is psychosis a neurobiological syndrome? Can J Psychiatry. 2004;49:713-718.
6. American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
7. Abrams R, Taylor MA. Catatonia. A prospective clinical study. Arch Gen Psychiatry. 1976;33:579-581.
8. Ungvari GS, Leung SK, Ng FS, Cheung HK, Leung T. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:27-38.
9. Fink M, Taylor A. Catatonia: A Clinician's Guide to Diagnosis and Treatment. New York, Cambridge University Press; 2003.
10. Bleuler E. Dementia Praecox or the Group of Schizophrenias (1908). Translated by Zinkin J; edited by Robertson GM. New York: International Universities Press; 1950.
11. Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia? Compr Psychiatry. 2002;43:167-174.
12. Oulis P, Lykouras L. Prevalence and diagnostic correlates of DSM-IV catatonic features among psychiatric inpatients. J Nerv Ment Dis. 1996;184:378-379.
13. Chandrasena R. Catatonic schizophrenia: an international comparative study. Can J Psychiatry. 1986;31:249-252.
14. Ohaeri JU. Long-term outcome of treated schizophrenia in a Nigerian cohort. Retrospective analysis of 7-year follow-ups. J Nerv Ment Dis. 1993;181:514-516.
15. Huang TL, Ree SC, Huang YC, Liu HY, Yang YY. Catatonic features: differential diagnosis and treatments at an emergency unit. Psychiatry Clin Neurosci. 1999;53:63-66.
16. Benegal V, Hingorani S, Khanna S. Idiopathic catatonia: validity of the concept. Psychopathology. 1993;26:41-46.
17. Lee JW, Schwartz DL, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry. 2000;12:89-96.
18. Fisher CM. 'Catatonia' due to disulfiram toxicity. Arch Neurol. 1989;46:798-804.
19. Gingrich JA, Rudnick-Levin F, Almeida C, Innes L, Schneier H. Cocaine and catatonia. Am J Psychiatry. 1998;155:1629.
20. Lee JW. Catatonic stupor after "ecstasy." BMJ. 1994;308:717-718.
21. Chouinard MJ, Nguyen DK, Clement JF, Bruneau MA. Catatonia induced by levetiracetam. Epilepsy Behav. 2006;8:303-307.
22. Carroll K GH. Catatonic signs in medical and psychiatric catatonias. CNS Spectrums. 2000;5:66-69.
23. Dhossche DM, Carroll BT, Carroll TD. Is there a common neuronal basis for autism and catatonia? Int Rev Neurobiol. 2006;72:151-164.
24. Cornic f CA, Cohen D. Catatonia in children and adolescents. Psychiatric Annals. 2007;37:19-26.
25. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996;93:129-136.
26. Braunig P, Kruger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry. 1998;39:35-46.
27. Kruger S BP. Catatonia in affective disorder: new findings and a review of the literature. CNS Spectrums. 2000;5:48-53.
28. Hare DJ, Malone C. Catatonia and autistic spectrum disorders. Autism. 2004;8:183-195.
29. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv. 1998;49:1163-1172.
30. Starkstein SE, Petracca G, Teson A, Chemerinski E, Merello M, Migliorelli R, Leiguarda R. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry. 1996;60:326-332.
31. Mimica N, Folnegovic-Smalc V, Folnegovic Z. Catatonic schizophrenia in Croatia. Eur Arch Psychiatry Clin Neurosci. 2001;251(Suppl 1):I17-I20.
32. Ungvari GS, Chiu HF, Chow LY, Lau BS, Tang WK. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl). 1999;142:393-398.
33. Clark T, Rickards H. Catatonia. 1: History and clinical features. Hosp Med. 1999;60:740-742.
34. Gjessing LR. A review of periodic catatonia. Biol Psychiatry. 1974;8:23-45.
35. Francis A, Divadeenam KM, Bush G, Petrides G. Consistency of symptoms in recurrent catatonia. Compr Psychiatry. 1997;38:56-60.
36. Clark T, Rickards H. Catatonia. 2: Diagnosis, management and prognosis. Hosp Med. 1999;60:812-814.
37. Northoff G, Koch A, Wenke J, Eckert J, Boker H, Pflug B, Bogerts B. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord. 1999;14:404-416.
38. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry. 1990;51:357-362.
39. Lohr J, Wisniewski AA. Catatonia. In: Lohr JB, Wisniewski AA (eds) Movement Disorders: A Neuropsychiatric Approach. New York: Guilford Press; 1987.
40. Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res. 1997;27:83-92.
41. Morrison JR. Catatonia: prediction of outcome. Compr Psychiatry. 1974;15:317-324.
42. Chalasani P, Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med. 2005;35:1667-1675.
43. Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 1):I8-I13.
44. Kruger S, Braunig P, Hoffler J, Shugar G, Borner I, Langkrar J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000;12:16-24.
45. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci. 1994;6:1-13.
46. White DA RA. Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry. 1991;158:419-421.
47. White D. Catatonia and the neuroleptic malignant syndrome - a single entity? Br J Psychiatry. 1992;161:558-560.
48. Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry. 1998;44:499-507.
49. Nisijima K, Kusakabe Y, Ohtuka K, Ishiguro T. Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome. Biol Psychiatry. 1998;44:930-931.
50. Ikebe S, Harada T, Hashimoto T, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Takubo H, Yanagisawa N, Narabayashi H. Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group. Parkinsonism Relat Disord. 2003;9 (Suppl 1):S47-S49.
51. Weller M, Kornhuber J. Amantadine withdrawal and neuroleptic malignant syndrome. Neurology. 1993;43:2155.
52. Berardi D, Amore M, Keck PE, Jr., Troia M, Dell'Atti M. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Biol Psychiatry. 1998;44:748-754.
53. Martin TG. Serotonin syndrome. Ann Emerg Med. 1996;28:520-526.
54. Kontaxakis VP, Havaki-Kontaxaki BJ, Christodoulou NG, Paplos KG, Christodoulou GN. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Ann Gen Hosp Psychiatry. 2003;2:10.
55. Peralta V, Cuesta MJ, Serrano JF, Martinez-Larrea JA. Classification issues in catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 1):I14-I16.
56. Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry. 1985;147:221-232.
57. McKenna PJ, Lund CE, Mortimer AM, Biggins CA. Motor, volitional and behavioural disorders in schizophrenia. 2: The 'conflict of paradigms' hypothesis. Br J Psychiatry. 1991;158:328-336.
58. Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci. 2002;25:555-604.
59. Northoff G, Eckert J, Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry. 1997;62:404-406.
60. Bauer G, Gerstenbrand F, Rumpl E. Varieties of the locked-in syndrome. J Neurol. 1979;221:77-91.
61. Altshuler LL, Cummings JL, Mills MJ. Mutism: review, differential diagnosis, and report of 22 cases. Am J Psychiatry. 1986;143:1409-1414.
62. Levin T, Martin R. Classification of catatonia. Am J Psychiatry. 2004;161:1136.
63. Swartz C, Francis A, Malur C. Delirium or catatonic disorder due to a general medical condition. J ECT. 2002;18:167-168.
64. Sadock BJ SV. Comprehensive Textbook of Psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2000.
65. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153:231-237.
66. Moskowitz AK. "Scared stiff": catatonia as an evolutionary-based fear response. Psychol Rev. 2004;111:984-1002.
67. Wetzel RD, Reich T, Murphy GE, Province M, Miller JP. The changing relationship between age and suicide rates: cohort effect, period effect or both? Psychiatr Dev. 1987;5:179-218.
68. Northoff G, Steinke R, Czcervenka C, Krause R, Ulrich S, Danos P, Kropf D, Otto H, Bogerts B. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999;67:445-450.
69. Mastain B, Vaiva G, Guerouaou D, Pommery J, Thomas P. [Favourable effect of zolpidem on catatonia]. Rev Neurol (Paris). 1995;151:52-56.
70. Thomas P, Rascle C, Mastain B, Maron M, Vaiva G. Test for catatonia with zolpidem. Lancet. 1997;349:702.
71. Seetharam P, Akerman RR. Postoperative echolalia and catatonia responsive to gamma aminobutyric acid receptor agonists in a liver transplant patient. Anesth Annals. 2006;103:785-786.
72. Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Kirvela O, Ruotsalainen U, Salokangas RKR. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet. 1995;346:1130-1131.
73. Northoff G, Steinke R, Nagel DC, Grosser O, Danos P, Genz A, Krause R, Boker H, Otto HJ, Bogerts B. Right lower prefrontoparietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol Med. 2000;30:583-596.
74. Northoff G, Kotter R, Baumgart F, Danos P, Boeker H, Kaulisch T, Schlagenhauf F, Walter H, Heinzel A, Witzel T, Bogerts B. Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr Bull. 2004;30:405-427.
75. Cavada C, Schultz W. The mysterious orbitofrontal cortex. foreword. Cereb Cortex. 2000;10:205.
76. Gehring WJ, Fencsik DE. Functions of the medial frontal cortex in the processing of conflict and errors. J Neurosci. 2001;21:9430-9437.
77. Satoh K, Narita M, Someya T, Fukuyama H, Yonekura Y. Functional brain imaging of a catatonic type of schizophrenia: PET and SPECT studies. Jpn J Psychiatry Neurol. 1993;47:881-885.
78. Ungvari GS, Leung HC, Lee TS. Benzodiazepines and the psychopathology of catatonia. Pharmacopsychiatry. 1994;27:242-245.
79. Schmider J, Standhart H, Deuschle M, Drancoli J, Heuser I. A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biol Psychiatry. 1999;46:437-441.
80. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137-143.
81. Gaind GS, Rosebush PI, Mazurek MF. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. J Clin Psychiatry. 1994;55:20-23.
82. Rosebush PI, Mazurek MF. Catatonia: re-awakening to a forgotten disorder. Mov Disord. 1999;14:395-397.
83. Wells DA. Electroconvulsive treatment for schizophrenia. A tenyear survey in a university hospital psychiatric department. Compr Psychiatry. 1973;14:291-298.
84. Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993;29:255-261.
85. Fricchione G. Catatonia: a new indication for benzodiazepines? Biol Psychiatry. 1989;26:761-765.
86. Van Den Eede F, Van Hecke J, Van Dalfsen A, Van den Bossche B, Cosyns P, Sabbe BG. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry. 2005;20:422-429.
87. Petrides G, Divadeenam KM, Bush G, Francis A. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry. 1997;42:375-381.
88. Thomas C, Carroll BT, Maley RT, Jayanti K, Koduri A. Memantine and catatonic schizophrenia. Am J Psychiatry. 2005;162:626.
89. Carpenter SS, Hatchett AD, Fuller MA. Catatonic schizophrenia and the use of memantine. Ann Pharmacother. 2006;40:344-346.
90. Kritzinger PR, Jordaan GP. Catatonia: an open prospective series with carbamazepine. Int J Neuropsychopharmacol. 2001;4:251-257.
91. McDaniel WW SD, Sahota AK. Topiramate efect in catatonia: a case series. J Neuropsychiatry Clin Neurosci. 2006;18:234-238.
92. Zaw ZF, Bates GD. Replication of zolpidem test for catatonia in an adolescent. Lancet. 1997;349:1914.
93. Cottencin O, Warembourg F, de Chouly de Lenclave MB, Lucas B, Vaiva G, Goudemand M, Thomas P. Catatonia and consultation-liaison psychiatry study of 12 cases. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1170-1176.
94. Pascual-Leone A, Catala MD, Pascual-Leone Pascual A. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology. 1996;46:499-502.
95. Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, Ben-Shachar D, Feinsod M. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry. 1999;56:315-320.
96. Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Charney DS. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet. 2000;355:1073-1075.
97. Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH. Catatonia treated with transcranial magnetic stimulation. Am J Psychiatry. 1998;155:1630.
98. Saba G, Rocamora JF, Kalalou K, Benadhira R, Plaze M, Aubriot-Delmas B, Januel D. Catatonia and transcranial magnetic stimulation. Am J Psychiatry. 2002;159:1794.
99. Pommepuy N, Januel D. [Catatonia: resurgence of a concept. A review of the international literature]. Encephale. 2002;28:481-492.
100. Fink M, Taylor MA, Ghaziuddin N. Catatonia in autistic spectrum disorders: a medical treatment algorithm. Int Rev Neurobiol. 2006;72:233-244.
101. Liddle PF. Commentary on the Modified Rogers Scale and the 'conflict of paradigms' hypothesis. Br J Psychiatry. 1991;158:337-339.